Probiotic Mix has Benefits in Relapsing Ulcerative Colitis


Adding a high-potency probiotic mix may improve the clinical picture of patients with ulcerative colitis on immunosuppresive therapy.

This video features discussion of a study that found that the addition of a high-potency probiotic mixture to the treatment regimen of patients with relapsing mild-to-moderate ulcerative colitis on immunosuppressive therapy may “improve the clinical picture” and allow these patients to avoid a new course of steroids.

Click here to access this third-party resource.

Related Videos
Connective Tissue Disease Brings Dermatology & Rheumatology Together
What Makes JAK Inhibitors Safe in Dermatology
Potential JAK Inhibitor Combination Regimens in Dermatology
Therapies in Development for Hidradenitis Suppurativa
"Prednisone without Side Effects": The JAK Inhibitor Ceiling in Dermatology
Discussing Changes to Atopic Dermatitis Guidelines, with Robert Sidbury, MD, MPH
How Will Upadacitinib, Povorcitinib Benefit Hidradenitis Suppurativa?
The JAK Inhibitor Safety Conversation
Jonathan Silverberg, MD, PhD, MPH | Credit: George Washington University
Secukinumab and Bimekizumab for Hidradenitis Suppurativa
© 2024 MJH Life Sciences

All rights reserved.